Panagora Asset Management’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-211,807
Closed -$17M 2529
2016
Q4
$17M Sell
211,807
-8,494
-4% -$674K 0.08% 258
2016
Q3
$17.6M Sell
220,301
-131,860
-37% -$10.6M 0.08% 239
2016
Q2
$27.5M Sell
352,161
-602,311
-63% -$42.9M 0.14% 158
2016
Q1
$52.5M Buy
954,472
+51,669
+6% +$2.82M 0.26% 86
2015
Q4
$55.8M Buy
902,803
+63,196
+8% +$3.99M 0.27% 88
2015
Q3
$53M Buy
839,607
+483,890
+136% +$34.5M 0.28% 90
2015
Q2
$26M Buy
355,717
+45,114
+15% +$3.26M 0.13% 173
2015
Q1
$20.3M Sell
310,603
-779,418
-72% -$51.8M 0.1% 222
2014
Q4
$70.9M Sell
1,090,021
-382,245
-26% -$24.6M 0.36% 68
2014
Q3
$88.5M Buy
1,472,266
+407,430
+38% +$26.6M 0.43% 63
2014
Q2
$73.7M Buy
1,064,836
+168,475
+19% +$10.9M 0.36% 73
2014
Q1
$58.6M Buy
896,361
+280,806
+46% +$18.3M 0.28% 93
2013
Q4
$38.1M Buy
615,555
+553,922
+899% +$32.1M 0.18% 127
2013
Q3
$3.31M Buy
61,633
+2,553
+4% +$131K 0.02% 634
2013
Q2
$2.7M Buy
+59,080
New +$2.56M 0.01% 669

Other funds holding STJ

Panagora Asset Management's STJ Position: Q1 2017 in Review

Panagora Asset Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 211,807 shares — an estimated $17M sold.

Panagora Asset Management first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $88.5M in Q3 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Panagora Asset Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Panagora Asset Management sold 211,807 St Jude Medical shares in Q1 2017, an estimated $17M.
  • Panagora Asset Management first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Panagora Asset Management's St Jude Medical position peaked at $88.5M in Q3 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Panagora Asset Management's 13F filing for Q1 2017, filed 15 May 2017.